⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

September 28, 2016American Journal of Clinical PathologyOpen Access

Stromal PD-L1 Expression Is Associated With Better Disease-Free Survival in Triple-Negative Breast Cancer

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

PD-L1 expression is seen in a high proportion of TNBCs and associated with better DFS.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Li et al. (2016) studied this question.

synapsesocial.com/papers/69d84d215c3030ff03d19c47 https://doi.org/10.1093/ajcp/aqw134

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Breast Cancer Subtypes and the Risk of Local and Regional RelapseOriginal Research · 2010 · 1,254 citations
2Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferationOriginal Research · 1983 · 2,847 citations
3Programmed Cell Death 1 (PD-1) and Its Ligand (PD-L1) in Common Cancers and Their Correlation with Molecular Cancer TypePrognostic Study · 2014 · 523 citations
4Clinical Significance and Therapeutic Potential of the Programmed Death-1 Ligand/Programmed Death-1 Pathway in Human Pancreatic CancerPrognostic Study · 2007 · 909 citations
5Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastomaOriginal Research · 2014 · 593 citations